This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Michigan. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Mark M Painter: Innovator in HIV Treatment
Introduction
Mark M Painter is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medical research, particularly in the treatment of HIV. His innovative approach has led to the development of a patent that addresses critical challenges in HIV infection management.
Latest Patents
Mark M Painter holds a patent for "Inhibitors of MHC-I Nef downmodulation for treating HIV." This patent provides compounds that can inhibit MHC-I downmodulation, offering a potential treatment for patients suffering from HIV infection. His work is crucial in advancing therapeutic options for those in need.
Career Highlights
Painter is affiliated with the University of Michigan, where he continues to engage in groundbreaking research. His dedication to improving health outcomes through innovation is evident in his work and contributions to the scientific community.
Collaborations
Mark M Painter has collaborated with esteemed colleagues, including Kathleen L Collins and Andrew W Robertson. These partnerships enhance the research efforts and broaden the impact of their findings in the field of HIV treatment.
Conclusion
Mark M Painter's contributions to HIV treatment through his innovative patent exemplify the importance of research and collaboration in addressing global health challenges. His work continues to inspire advancements in medical science.